# Emma Walmsley
Principales episodios de podcast
Actualizado:
Dame Emma Natasha Walmsley (born June 1969) is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016.
Pharma and Biotech Daily: Top Stories in the Industry from Zenas to Lilly
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Zenas has made a $2 billion bet on autoimmune diseases with Chinese firm InnoCare, focusing on the development of orelabrutinib for multiple sclerosis. Former FDA director …
Episode 159 - October 17, 2025
On this week’s episode, Paul Matteis, John Maraganore, Eric Schmidt, and Graig Suvannavejh open with a look at biotech market sentiment, which has notably strengthened amid steady M&A and successful drug launches. The XBI is also up over 40% in six months, signaling optimism that the long “biotech …
HITshow Daily: October 29, 2025 (Wednesday)
Today on HITshow:
Silicon Valley gets a billion-dollar hospital bet, and payers face mounting pressures. Today's HITshow Daily spotlights HCA's $1.3 billion Good Samaritan expansion, Centene's $6.6 billion Q3 loss, and ACA marketplace sticker shock as subsidies expire. Then in our second half, A…
2025’s Fiercest Women in Life Sciences are changing the game
Research shows that women remain woefully underrepresented at the highest levels of leadership in the life sciences industry. Those who have broken through that glass ceiling, however, are not only doing groundbreaking work in pharma, biotech, medtech and beyond but also reframing what it means to …
The New Rules for Leadership
Watch all of the day’s interviews.
The modern business leader walks a tightrope: between fighting for the success of their company and shareholder value; between communication and leadership ability, demands for innovation, media representation, political pressures and international dynamics and be…
GSK CEO: Why We Prioritise USA Over UK
(Episode 16) Dame Emma Walmsley, Chief Executive one of Britain's biggest pharmaceutical companies GSK (GlaxoSmithKline), says the company is prioritising the United States for product launches and investment, citing its scale, commercial opportunities and favourable business environment. She confi…
Is answering 3 questions really all it takes?
Episode notes
In this week's podcast Allan reviews an interesting book by Ken Fisher, shares an article on weight-loss drugs, and a podcast interview with a big pharma CEO.
Allan's thought for the week
Amazing: I'm now an ice cream vendor.
Book of the week
Ken Fisher is the son of the great Ph…
🧬 People Aren’t Rational: Why That’s an Advantage as a Leader | Jason C. Foster Re-Release (1/2)
🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.
As a TBSP listener, you can get exclusive perks through Excedr’s par…
Emma Walmsley on Leading and Leaving GSK
What does it take to hand over a company after years at the helm? Dame Emma Walmsley reflects on her tenure as CEO of GSK at the moment she was preparing to hand over to her successor, Luke Miels. It’s a rare chance to hear a CEO reflect on the full arc of their tenure, from stepping into the role …
Macy’s CEO, GSK CEO & Paychex CEO 3/29/23
All major market averages ended the day higher, with the NASDAQ taking the biggest lead by growing over 200 points, and Cramer is diving into how company’s are reacting to another positive day of growth. First, Jim sits down with Macy’s CEO Jeff Gennette to learn how the company is guiding its way …
MOTOR DE BÚSQUEDA DE PODCAST
Puede utilizar nuestro sitio web para buscar podcasts de3,830,426y episodios de196,607,320por personas, lugares o temas.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.
